Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term immunogenicity follow-up of Adacel booster vaccination in adolescents and adults
2015-005845-30Phase 3
- Sponsor
- Sanofi
- Start
- Jan 2016
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes, Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3 trial of acellular pertussis vaccine and tetanus and diphtheria toxoids adsorbed in Tetanus, diphtheria and pertussis (2 arms), sponsored by Sanofi. Primary endpoints: Pertussis antibody levels at long-term follow-up, Diphtheria antibody levels at long-term follow-up and 1 more.
02
Drugs
acellular pertussis vaccinetetanus and diphtheria toxoids adsorbed
03
Conditions
Tetanusdiphtheriapertussis
Beyond the preview
Go deeper on 2015-005845-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005845-30.